3',5'-Di-O-benzoyl fialuridine

Catalog No. :
ACLIZK533
CAS No. :
97614-45-4
Molecular Formula :
C23H18FIN2O7
Molecular Weight :
580.31

IUPAC Name:((2R,3R,4S,5R)-3-(benzoyloxy)-4-fluoro-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl benzoate

3',5'-Di-O-benzoyl fialuridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$609.00Login to see priceInquiryInquiry
1g97%$1524.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3',5'-Di-O-benzoyl fialuridine
IUPAC Name((2R,3R,4S,5R)-3-(benzoyloxy)-4-fluoro-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl benzoate
Molecular FormulaC23H18FIN2O7
Molecular Weight580.31
SMILESO=C1NC(C(I)=CN1[C@H]2[C@@H](F)[C@@H]([C@@H](COC(C3=CC=CC=C3)=O)O2)OC(C4=CC=CC=C4)=O)=O
InChI KeyFBENGCVQLDKVAT-AJYBTWMASA-N
Synonym3',5'-Di-O-benzoyl Fialuridine;5-iodo-1-(2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl-β-D-arabinofuranosyl)uracil;5-Iodo-3',5'-bis-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinouridine;1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodo-2,4(1H,3H)-pyrimidinedione;5-Iodo-3’,5’-bis-O-benzoyl-2’-deoxy-2’-fluoro-β-D-arabinouridine;2,4(1H,3H)-Pyrimidinedione, 1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodo-;3’,5’-Di-O-benzoylFialuridine;3′,5′-Di-O-benzoyl Fialuridine, CAS 97614-45-4
CAS No.97614-45-4

Synthetic Route by SureRoute

1. ACLIZK533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIZK533 route product structure diagram
    ACLIZK53397614-45-4
Inquiry

2. ACLIZK533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIZK533 route product structure diagram
    ACLIZK53397614-45-4
Inquiry

Comments (0)